Global Short Peripheral Intravenous Catheters Market Size By Type (Ported Short PIVC, Non-Ported Short PIVC), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Short Peripheral Intravenous Catheters Market was valued at USD 5.9 billion in 2023 and is projected to surpass USD 9.7 billion by 2031, growing at a CAGR of 6.6% during the forecast period (2023–2031). Short peripheral intravenous (IV) catheters are the most commonly used vascular access devices in clinical settings for the administration of fluids, medications, and nutrients. Market growth is fueled by increasing hospital admissions, rising incidences of chronic diseases, and the growing adoption of minimally invasive procedures. Additionally, technological advancements in catheter design and materials are improving patient comfort and reducing complications, further driving demand.

Drivers

1. Rising Hospitalization Rates

The surge in both elective and emergency hospital admissions, particularly among the elderly and chronically ill patients, is a key driver. These populations often require repeated or long-term intravenous access, increasing demand for short peripheral IV catheters.

2. Increasing Prevalence of Chronic Diseases

Conditions like cancer, cardiovascular diseases, and diabetes necessitate frequent intravenous treatments, directly contributing to the rising usage of peripheral IV catheters.

3. Advances in Catheter Technology

Manufacturers are focusing on improved catheter materials (e.g., polyurethane and Teflon), safety-engineered devices, and antimicrobial coatings, which enhance usability and minimize infection risks.

Restraints

1. Risk of Catheter-Related Complications

Complications such as phlebitis, infiltration, and bloodstream infections can lead to negative patient outcomes and increased healthcare costs, limiting wider adoption.

2. Availability of Alternative Delivery Methods

The increasing use of central venous access devices (CVADs) and peripherally inserted central catheters (PICCs) for long-term therapy can restrict the growth of short peripheral IV catheter usage in certain clinical scenarios.

Opportunity

1. Expansion of Home Healthcare Services

With healthcare models shifting toward home-based care, there is a growing need for easy-to-use, safe, and efficient peripheral IV catheters that can be administered outside traditional hospital settings.

2. Growing Demand in Emerging Markets

Rising healthcare investments, growing awareness, and improving hospital infrastructure in Asia-Pacific, Latin America, and Africa present substantial growth opportunities.

Market by System Type Insights

Based on system type, the Integrated/Closed IV Catheters segment held the largest market share in 2023. These catheters offer enhanced safety with reduced needlestick injuries and lower infection risk, making them preferable in both high- and low-resource settings. The Conventional IV Catheters segment is expected to grow steadily, particularly in cost-sensitive markets where affordability remains a primary concern.

Market by End-use Insights

The Hospitals segment dominated the global market in 2023, driven by the high patient inflow and routine need for intravenous therapy in surgical, emergency, and critical care units. The Homecare Settings segment is poised to witness the highest growth during the forecast period, supported by the increasing preference for outpatient treatments and advancements in user-friendly catheter designs.

Market by Regional Insights

In 2023, North America emerged as the leading region, accounting for the largest revenue share due to advanced healthcare infrastructure, high chronic disease burden, and early adoption of innovative catheter technologies. Meanwhile, Asia-Pacific is projected to register the fastest growth, driven by rapid urbanization, rising healthcare expenditure, and a growing elderly population.

Competitive Scenario

Key players in the Global Short Peripheral Intravenous Catheters Market include:

Becton, Dickinson and Company (BD)

B. Braun Melsungen AG

Smiths Medical (ICU Medical)

Terumo Corporation

Teleflex Incorporated

Nipro Corporation

Medline Industries, LP

Vygon SA

These companies are actively investing in R&D, regulatory approvals, product launches, and geographic expansion. For example:

In 2023, BD launched a next-generation IV catheter system with integrated stabilization and antimicrobial features to reduce complications.

Terumo Corporation expanded its IV catheter manufacturing facility in Southeast Asia in 2024 to meet growing demand in emerging markets.

Scope of Work – Global Short Peripheral Intravenous Catheters Market

Report Metric Details

Market Size (2023) USD 5.9 billion

Projected Market Size (2031) USD 9.7 billion

CAGR (2023–2031) 6.6%

Market Segments System Type (Integrated, Conventional), End-use, Region

Growth Drivers Rising hospitalizations, chronic diseases, catheter innovations

Opportunities Home healthcare, emerging market expansion

Key Market Developments

2023: BD launched an antimicrobial-coated catheter with improved patient safety profile and usability in outpatient settings.

2024: Smiths Medical (ICU Medical)